The New Rules of Retina Drug Development - Top-Institutions - MDSpire

The New Rules of Retina Drug Development

In a panel at the Retina Innovation Summit in Montreal, regulatory experts, drug developers, academic advisors, and investors discussed how evolving FDA guidance is reshaping the path from clinical trials to approval.

  • By

  • Jim Gallagher, senior managing editor

  • July 15, 2026

  • 5 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, Florida

    Key Differentiators

    • Ophthalmology

  • #2

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology

  • #3

    New York Eye and Ear Infirmary of Mount Sinai
    New York Eye and Ear Infirmary of Mount Sinai

    New York, New York

    Key Differentiators

    • Ophthalmology

  • #4

    Penn State University
    Penn State University

    University Park, Pennsylvania

    Key Differentiators

    • Ophthalmology

  • #5

    University of California at Berkeley
    University of California at Berkeley

    Berkeley, California

    Key Differentiators

    • Ophthalmology

Original Source(s)

The New Rules of Retina Drug Development

  • by Jim Gallagher, senior managing editor

  • July 15, 2026

Related Content

Applications of dynamic gratings in neuro-ophthalmic disorders

Endogenous Endophthalmitis and Missed Diagnoses

Retrospective study describes how endogenous endophthalmitis often presents without systemic symptoms

  • July 21, 2026

  • 3 min
Symptomatic intraocular pressure dysregulation during clopidogrel exposure after patent foramen ovale closure in a patient with ocular hypertension and angle crowding: a Case Report